Cargando…
Novel Snakebite Therapeutics Must Be Tested in Appropriate Rescue Models to Robustly Assess Their Preclinical Efficacy
In the field of antivenom research, development, and manufacture, it is often advised to follow the World Health Organization’s (WHO) guidelines for the production, control, and regulation of snake antivenom immunoglobulins, which recommend the use of preincubation assays to assess the efficacy of s...
Autores principales: | Knudsen, Cecilie, Casewell, Nicholas R., Lomonte, Bruno, Gutiérrez, José María, Vaiyapuri, Sakthivel, Laustsen, Andreas H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551497/ https://www.ncbi.nlm.nih.gov/pubmed/32824899 http://dx.doi.org/10.3390/toxins12090528 |
Ejemplares similares
-
Recent Advances in Next Generation Snakebite Antivenoms
por: Knudsen, Cecilie, et al.
Publicado: (2018) -
Clinical management of snakebite envenoming: Future perspectives
por: Hamza, Muhammad, et al.
Publicado: (2021) -
Snakebite Envenoming Diagnosis and Diagnostics
por: Knudsen, Cecilie, et al.
Publicado: (2021) -
Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead
por: Gutiérrez, José María, et al.
Publicado: (2017) -
The Failures of Ethnobotany and Phytomedicine in Delivering Novel Treatments for Snakebite Envenomation
por: Trim, Steven A., et al.
Publicado: (2020)